Home > Annual Financials > AAREY DRUGS & PHARMACEUTICALS

AAREY DRUGS & PHARMACEUTICALS Financial Statement Analysis
[BOM: 524412|NSE : AAREYDRUGS]

The Revenues of AAREY DRUGS & PHARMACEUTICALS have decreased by -0.35% YoY .
The Earnings Per Share (EPS) of AAREY DRUGS & PHARMACEUTICALS has decreased by -1.42 % YoY.
COMMUNITY POLL
for AAREY DRUGS & PHARMACEUTICALS
Please provide your vote to see the results

AAREY DRUGS & PHARMACEUTICALS Last 5 Annual Financial Results
[BOM: 524412|NSE : AAREYDRUGS]

StandaloneMar2026
Mar2025
Mar2024
Mar2023
Mar2022
Revenues ₹472 Cr₹474 Cr₹398 Cr₹419 Cr₹493 Cr
Expenses ₹465 Cr₹471 Cr₹391 Cr₹411 Cr₹481 Cr
Operating Profit (Excl OI) ₹7.17 Cr₹2.90 Cr₹6.48 Cr₹7.72 Cr₹11 Cr
Other Income ₹6.10 Cr₹9.81 Cr₹4.94 Cr₹2.73 Cr₹2.67 Cr
Interest ₹5.00 Cr₹4.66 Cr₹4.38 Cr₹2.87 Cr₹2.04 Cr
Depreciation ₹2.85 Cr₹1.95 Cr₹1.70 Cr₹1.57 Cr₹1.99 Cr
Profit Before Tax ₹5.41 Cr₹6.10 Cr₹5.34 Cr₹6.01 Cr₹10 Cr
Profit After Tax ₹3.97 Cr₹4.02 Cr₹4.68 Cr₹3.77 Cr₹6.56 Cr
Earnings Per Share (Rs)₹1.39₹1.41₹1.67₹1.49₹2.58
PAT Margin (%)0.840.851.180.901.33
ROE(%)2.813.023.823.336.31
ROCE(%)5.576.386.096.289.87
Total Debt/Equity(x)0.340.260.240.330.13

Key Financials

Market Cap : ₹ 349.9 Cr
Revenue (TTM) : ₹ 414.7 Cr
Net Profit(TTM) : ₹ 4.2 Cr
EPS (TTM) : ₹ 1.3
P/E (TTM) : 83.8

Industry Peers & Returns1W1M1Y
AAREY DRUGS & PHARMACEUTICALS 1.2% 7.5% 31.9%
ADANI ENTERPRISES -5.9% -15% 5.6%
PREMIER ENERGIES -5% -5.2% -16.9%
ADITYA INFOTECH -5% 11.9% 174.6%
AEGIS LOGISTICS -7.5% -12.3% 63%
REDINGTON -6.4% -6.4% 30.5%
RRP SEMICONDUCTOR -3.9% -19% 4545.9%
HONASA CONSUMER -1.3% -6.6% 54.7%
LLOYDS ENTERPRISES -9.6% -9.6% -3.8%


AAREY DRUGS & PHARMACEUTICALS Revenues
[BOM: 524412|NSE : AAREYDRUGS]

Y-o-Y

-0.35 %

5 Yr CAGR

-1.06 %

Years Revenues % Change
Mar2026 ₹472 Cr
-0.35
Mar2025 ₹474 Cr
19.19
Mar2024 ₹398 Cr
-5.09
Mar2023 ₹419 Cr
-14.98
Mar2022 ₹493 Cr -


AAREY DRUGS & PHARMACEUTICALS Operating Profit
[BOM: 524412|NSE : AAREYDRUGS]

Y-o-Y

147.41 %

5 Yr CAGR

-10.94 %

Years Operating Profit % Change
Mar2026 ₹7.17 Cr
147.41
Mar2025 ₹2.90 Cr
-55.28
Mar2024 ₹6.48 Cr
-16.06
Mar2023 ₹7.72 Cr
-32.25
Mar2022 ₹11 Cr -

Operating Margins
Y-o-Y

149.18 %

5 Yr CAGR

-9.93 %

Years Operating Margin% % Change
Mar2026 1.52%
149.18
Mar2025 0.61%
-62.58
Mar2024 1.63%
-11.41
Mar2023 1.84%
-20.35
Mar2022 2.31% -

AAREY DRUGS & PHARMACEUTICALS Profit After Tax
[BOM: 524412|NSE : AAREYDRUGS]

Y-o-Y

-1.39 %

5 Yr CAGR

-11.79 %

Years Profit After Tax % Change
Mar2026 ₹3.97 Cr
-1.39
Mar2025 ₹4.02 Cr
-14.09
Mar2024 ₹4.68 Cr
24.21
Mar2023 ₹3.77 Cr
-42.47
Mar2022 ₹6.56 Cr -

PAT Margins
Y-o-Y

-1.18 %

5 Yr CAGR

-10.85 %

Years PAT Margin(%) % Change
Mar2026 0.84 %
-1.18
Mar2025 0.85 %
-27.97
Mar2024 1.18 %
31.11
Mar2023 0.9 %
-32.33
Mar2022 1.33 % -

AAREY DRUGS & PHARMACEUTICALS Earnings Per Share (EPS)
[BOM: 524412|NSE : AAREYDRUGS]

Y-o-Y

-1.42 %

5 Yr CAGR

-14.33 %

Years EPS % Change
Mar2026 ₹1.39
-1.42
Mar2025 ₹1.41
-15.57
Mar2024 ₹1.67
12.08
Mar2023 ₹1.49
-42.25
Mar2022 ₹2.58 -

AAREY DRUGS & PHARMACEUTICALS Return on Capital Employed (ROCE)
[BOM: 524412|NSE : AAREYDRUGS]

Y-o-Y

-12.70 %

5 Yr CAGR

-13.33 %

Years ROCE % Change
Mar2026 5.57%
-12.70
Mar2025 6.38%
4.76
Mar2024 6.09%
-3.03
Mar2023 6.28%
-36.37
Mar2022 9.87% -

AAREY DRUGS & PHARMACEUTICALS Share Price vs Sensex

Current Share Price : ₹109.7
Current MarketCap: ₹ 349.9 Cr
Updated EOD on :Oct 22,2026

Share Price Returns(%) 1 Week 1 Month 1 Year
AAREY DRUGS & PHARMACEUTICALS

1.2%

7.5%

31.9%

SENSEX

0.6%

-1.4%

-10.7%

AAREY DRUGS & PHARMACEUTICALS related INDICES

No BSE index found!
No NSE index found

You may also like the below Video Courses


FAQ about AAREY DRUGS & PHARMACEUTICALS Financials


How the annual revenues of AAREY DRUGS & PHARMACEUTICALS have changed ?

The Revenues of AAREY DRUGS & PHARMACEUTICALS have decreased by -0.35% YoY .

How the Earnings per Share (EPS) of AAREY DRUGS & PHARMACEUTICALS have changed?

The Earnings Per Share (EPS) of AAREY DRUGS & PHARMACEUTICALS has decreased by -1.42 % YoY .